Advertisement

Perinatal lethal Gaucher disease: A case report and review of literature

      Abstract

      Perinatal lethal Gaucher disease is a very rare variant of type 2 Gaucher disease that occurs in the neonatal period and leads to death in early infancy. The disease is characterized by hydrops fetalis or a collodion baby phenotype accompanied with progressive neurological manifestations, hepatosplenomegaly, thrombocytopenia, anemia, and failure to thrive. We report a case of perinatal lethal Gaucher disease treated with enzyme replacement therapy (ERT) who survived for 9 months and present a literature review of perinatal lethal Gaucher disease cases. The prognosis of perinatal lethal Gaucher disease is poor, and ERT is only effective in visceral manifestation. Therefore, palliative care should be recognized as a treatment option, and ERT employment needs to be discussed in this context.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Brain and Development
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Lal T.R.
        • Seehra G.K.
        • Steward A.M.
        • Poffenberger C.N.
        • Ryan E.
        • Tayebi N.
        • et al.
        The natural history of type 2 Gaucher disease in the 21st century: a retrospective study.
        Neurology. 2020; 95: e2119-e2130
        • Mignot C.
        • Gelot A.
        • Bessières B.
        • Daffos F.
        • Voyer M.
        • Menez F.
        • et al.
        Perinatal-lethal Gaucher disease.
        Am J Med Genet A. 2003; 120A: 338-344
        • Uchiyama A.
        • Tomatsu S.
        • Kondo N.
        • Suzuki Y.
        • Shimozawa N.
        • Fukuda S.
        • et al.
        New Gaucher disease mutations in exon 10: a novel L444R mutation produces a new NciI site the same as L444P.
        Hum Mol Genet. 1994; 3: 1183-1184
        • Sidransky E.
        • Tayebi N.
        • Stubblefield B.K.
        • Eliason W.
        • Klineburgess A.
        • Pizzolato G.P.
        • et al.
        The clinical, molecular, and pathological characterisation of a family with two cases of lethal perinatal type 2 Gaucher disease.
        J Med Genet. 1996; 33: 132-136
        • Tayebi N.
        • Cushner S.R.
        • Kleijer W.
        • Lau E.K.
        • Damschroder-Williams P.J.
        • Stubblefield B.K.
        • et al.
        Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene.
        Am J Med Genet. 1997; 73: 41-47
        • Rowlands S.
        • Murray H.
        Prenatal ultrasound findings in a fetus diagnosed with Gaucher’s disease (type 2) at birth.
        Prenat Diagn. 1997; 17: 765-769
        • Reissner K.
        • Tayebi N.
        • Stubblefield B.K.
        • Koprivica V.
        • Blitzer M.
        • Holleran W.
        • et al.
        Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
        Mol Genet Metab. 1998; 63: 281-288
        • Tayebi N.
        • Reissner K.J.
        • Lau E.K.
        • Stubblefield B.K.
        • Klineburgess A.C.
        • Martin B.M.
        • et al.
        Genotypic heterogeneity and phenotypic variation among patients with type 2 Gaucher's disease.
        Pediatr Res. 1998; 43: 571-578
        • Stone D.L.
        • van Diggelen O.P.
        • de Klerk J.B.
        • Gaillard J.L.
        • Niermeijer M.F.
        • Willemsen R.
        • et al.
        Is the perinatal lethal form of Gaucher disease more common than classic type 2 Gaucher disease?.
        Eur J Hum Genet. 1999; 7: 505-509
        • Chabás A.
        • Gort L.
        • Díaz-Font A.
        • Montfort M.
        • Santamaría R.
        • Cidrás M.
        • et al.
        Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease.
        Blood Cells Mol Dis. 2005; 35: 253-258
        • Akdag A.
        • Oğuz S.S.
        • Ezgü F.
        • Erdeve O.
        • Uraş N.
        • Dilmen U.
        A newborn case with perinatal-lethal Gaucher disease due to R463H homozygosity complicated by C677T homozygosity in the MTHFR gene.
        J Pediatr Endocrinol Metab. 2011; 24: 381-383
        • Goebl A.
        • Ferrier R.A.
        • Ferreira P.
        • Pinto-Rojas A.
        • Matshes E.
        • Choy F.Y.M.
        Gaucher disease with prenatal onset and perinatal death due to compound heterozygosity for the missense R131C and null Rec Nci I GBA mutations.
        Pediatr Dev Pathol. 2011; 14: 240-243
      1. Koyano K, Nii K, Jinnai W, Kondo S, Yasuda S, Kusaka T. A case of perinatal lethal Gaucher disease diagnosed by characteristic skin, hepatosplenomegaly, and thrombocytopenia. Gaucher Dis Casebook. 2015:26-30 (Japanese).

        • Adachi H.
        • Noguchi A.
        • Ota S.
        • Takahashi T.
        • Nanjo H.
        Bronchoalveolar lavage fluid in an infant with perinatal lethal Gaucher disease.
        Pediatr Int. 2017; 59: 636-637
        • Momosaki K.
        • Kido J.
        • Matsumoto S.
        • Yoshida S.
        • Takei A.
        • Miyabayashi T.
        • et al.
        High-risk screening for Gaucher disease in patients with neurological symptoms.
        J Hum Genet. 2018; 63: 717-721
        • Bulut F.D.
        • Kör D.
        • Şeker-Yılmaz B.
        • Hergüner Ö.
        • Ceylaner S.
        • Özkınay F.
        • et al.
        Four Gaucher disease type II patients with three novel mutations: a single centre experience from Turkey.
        Metab Brain Dis. 2018; 33: 1223-1227
        • Bhutada E.
        • Pyragius T.
        • Petersen S.G.
        • Niemann F.
        • Matsika A.
        Perinatal lethal Gaucher disease due to RecNcil recombinant mutation in the GBA gene presenting with Hydrops fetalis and severe congenital anemia.
        Case Rep Pathol. 2018; 2018: 2549451
        • Wei M.
        • Han A.
        • Wei L.
        • Ma L.
        A neonatal case with perinatal lethal Gaucher disease associated with missense G234E and H413P heterozygous mutations.
        Front Pediatr. 2019; 7: 201
        • Ebihara G.
        • Matsushita Y.
        • Kirino M.
        • Hikino S.
        • Sato K.
        An infant with type II Gaucher disease treated with enzyme replacement therapy.
        Pediatr Int. 2022; 64: e14873
        • Tayebi N.
        • Stubblefield B.K.
        • Park J.K.
        • Orvisky E.
        • Walker J.M.
        • LaMarca M.E.
        • et al.
        Reciprocal and nonreciprocal recombination at the glucocerebrosidase gene region: implications for complexity in Gaucher disease.
        Am J Hum Genet. 2003; 72: 519-534